You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Caring Brands, Inc. registers up to 24,513,943 shares for resale following a Series B financing that raised $7,149,900 gross. Nasdaq has not confirmed regained compliance after the company’s July 15, 2026 delisting determination was appealed.
Caring Brands, Inc. established a $0.16 per share Series A conversion-price floor, effective September 22, 2026, and $0.266 per share Series B conversion-price and PIPE warrant exercise-price floors, effective September 30, 2026.
Caring Brands, Inc. appointed Brian R. Meadows CFO effective September 18, 2026, increased Myall Luna Ventures Inc.’s monthly consulting fee from $10,000 to $15,000, named Dr. Glynn Wilson Chairman, and reported Brian John’s CFO and board departures on September 16, 2026.
Useful current figures from the complete screener profile.
* Q4 derived as the full year minus Q1 to Q3.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CABR
this stock
Caring Brands, Inc.
|
$8.34M | -6.3% | — | — | 0.1% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$67.48B | +35.5% | — | — | 0.1% |
|
GALDY
Galderma Group AG
|
$54.01B | +11.7% | — | — | 0.0% |
|
TEVA
Teva Pharmaceutical Industries Ltd
|
$50.93B | +39.9% | +4.3% | 99.2 | 2.4% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
|
$40.66B | — | — | — | 0.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Caring Brands, Inc. registers up to 24,513,943 shares for resale following a Series B financing that raised $7,149,900 gross. Nasdaq has not confirmed regained compliance after the company’s July 15, 2026 delisting determination was appealed.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CABR | +7.2% | -37.5% | -30.1% | -28.8% | -6.3% |
| SPY | +3.3% | -1.9% | +1.5% | +0.2% | +11.0% |
| vs SPY | +4.0% | -35.6% | -31.6% | -29.0% | -17.3% |
